4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
MedKoo(授权代理)
主营:主营:抗癌化学试剂和激酶抑制剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > MedKoo/格尔达那霉素/50mg/205922
商品详细MedKoo/格尔达那霉素/50mg/205922
MedKoo/格尔达那霉素/50mg/205922
MedKoo/格尔达那霉素/50mg/205922
商品编号: 205922
品牌: MedKoo
市场价: ¥1800.00
美元价: 1080.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Geldanamycin
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#:205922

CAS#:30562-34-6

Description:Geldanamycin is a benzoquinone ansamycin antibiotic that binds to Hsp90 (Heat Shock Protein 90) and inhibits its function. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis. Hsp90-geldanamycin complex. PDB 1yet Geldanamycin induces the degradation of proteins that are mutated in tumor cells such as v-Src, Bcr-Abl and p53 preferentially over their normal cellular counterparts. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate (namely, hepatotoxicity) that have led to the development of geldanamycin analogues.

Price and Availability

SizePriceShipping out timeQuantity
50mgUSD 90Same day
100mgUSD 150Same day
200mgUSD 250Same day
500mgUSD 450Same day
1gUSD 750Same day
2gUSD 1350Same day
5gUSD 2950Same day
10gUSD 52502 Weeks
20gUSD 88502 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-23.Prices are subject to change without notice.

Geldanamycin, purity > 98%, is in stock. The same say shipping after order is received.

Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 205922Name: GeldanamycinCAS#: 30562-34-6Chemical Formula: C29H40N2O9Exact Mass: 560.27338Molecular Weight: 560.6359Elemental Analysis: C, 62.13; H, 7.19; N, 5.00; O, 25.68

Synonym:NSC 122750; NSC-122750; NSC122750; U 29135; U-29135; U29135. Geldanamycin.

IUPAC/Chemical Name:(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate

InChi Key:QTQAWLPCGQOSGP-KSRBKZBZSA-N

InChi Code:InChI=1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1

SMILES Code:NC(O[C@@H](/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC1=C2OC)[C@@H](OC)/C=CC=C(C)C(NC(C1=O)=CC2=O)=O)=O

Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:
View CoA: current batch, Lot#A20T10K11

QC Data:
View QC data: current batch, Lot#A20T10K11

Safety Data Sheet (SDS):
View Safety Data Sheet (SDS)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Additional Information

Geldanamycin was originally discovered in the organism Streptomyces hygroscopicus. It is a macrocyclic polyketide that is synthesized by a Type I polyketide synthase. The genes gelA, gelB, and gelC encode for the polyketide synthase. The PKS is first loaded with 3-amino-5-hydroxybenzoic acid (AHBA). It then utilizes malonyl-CoA, methylmalonyl-CoA, and methoxymalonyl-CoA to synthesize the precursor molecule Progeldanamycin.   This precursor is subjected to several enzymatic and non-enzymatic tailoring steps to produce the active molecule Geldanamycin, which include hydroxylation, o-methylation, carbamoylation, and oxidation.      

References

1: Gorska M, Popowska U, Sielicka-Dudzin A, Kuban-JankowskaA, Sawczuk W, Knap N, Cicero G, Wozniak F. Geldanamycin and itsderivatives as Hsp90 inhibitors. Front Biosci. 2012 Jun 1;17:2269-77.Review. PubMed PMID: 22652777.

2: Fukuyo Y, Hunt CR, Horikoshi N. Geldanamycin and its anti-canceractivities. Cancer Lett. 2010 Apr 1;290(1):24-35. Epub 2009 Oct 21.Review. PubMed PMID: 19850405.

3: Hadden MK, Lubbers DJ, Blagg BS. Geldanamycin, radicicol, andchimeric inhibitors of the Hsp90 N-terminal ATP binding site. Curr TopMed Chem. 2006;6(11):1173-82. Review. PubMed PMID: 16842154.

4: Chiosis G, Caldas Lopes E, Solit D. Heat shock protein-90 inhibitors:a chronicle from geldanamycin to today"s agents. Curr Opin InvestigDrugs. 2006 Jun;7(6):534-41. Review. PubMed PMID: 16784024.

5: Neckers L. Chaperoning oncogenes: Hsp90 as a target of geldanamycin.Handb Exp Pharmacol. 2006;(172):259-77. Review. PubMed PMID: 16610363.

6: Miyata Y. Hsp90 inhibitor geldanamycin and its derivatives as novelcancer chemotherapeutic agents. Curr Pharm Des. 2005;11(9):1131-8.Review. PubMed PMID: 15853661.

7: Sausville EA. Geldanamycin analogs. J Chemother. 2004 Nov;16 Suppl4:68-9. Review. PubMed PMID: 15688614.

8: Liao ZY, Zhen YS. [Advances in antitumor activity of the hsp90inhibitor geldanamycin]. Yao Xue Xue Bao. 2001 Sep;36(9):716-20. Review.Chinese. PubMed PMID: 12580116.

9: Blagosklonny MV. Hsp-90-associated oncoproteins: multiple targets ofgeldanamycin and its analogs. Leukemia. 2002 Apr;16(4):455-62. Review.PubMed PMID: 11960322.

10: Ochel HJ, Eichhorn K, Gademann G. Geldanamycin: the prototype of aclass of antitumor drugs targeting the heat shock protein 90 family ofmolecular chaperones. Cell Stress Chaperones. 2001 Apr;6(2):105-12.Review. Erratum in: Cell Stress Chaperones 2001 Jul;6(3):295. PubMedPMID: 11599571; PubMed Central PMCID: PMC434387.

品牌介绍
MedKoo 美帝药库公司以药物化学合成技术为核心,密切结合全球抗癌新药研发领域中的新技术、新理论、新趋势和新的发展方向,不断推出抗癌化合物新品种。 。 美帝药库MedKoo将在中国建立药物化学合成生产基地和多个现代化药物化合物存储仓库。 美帝药库的药物化合物来源于以下几个渠道:自主合成、委托化学合成、合作伙伴、和从国内外市场上选购。 MedKoo美帝药库的抗癌分子库 MedKoo的目标是打造全球规模最大、品种最多、类别最全和质量最好的小分子抗癌化合物库。MedKoo的抗癌药库将由下列5个分子库组成: (1)上市抗癌药库:该库将含有大约100个全球已批准上市的小分子抗癌化合物; (2)抗癌候选药物库:该分子库含有大约400个世界各国正在临床研究中抗癌小分子候选药物; (3)同系抗癌分子库:该分子库将含有多个化学结构类似或抗癌机制类似的分子包; (4)抗癌分子预制模块库:该库主要含有用于组建抗癌目标分子的分子模块包; (5)同位素标记抗癌分子库。